GABINET LEKARSKI PSYCHIATRYCZNY IRENEUSZ KACZOROWSKI
- Address
- ul. Kotarbińskiego 14, 97-400 Bełchatów, Poland
GABINET LEKARSKI PSYCHIATRYCZNY IRENEUSZ KACZOROWSKI - Psychiatric Research Center
This specialized psychiatric clinical research facility focuses on advancing treatment options for patients with severe mental health conditions. The center participates in multinational clinical trial programs evaluating novel therapeutic approaches for complex psychiatric disorders.
- Long-term safety evaluation of investigational psychiatric medications
- Cognitive impairment associated with schizophrenia
- Phase III clinical trials for advanced-stage psychiatric therapeutics
The center demonstrates expertise in conducting extension studies that monitor long-term safety outcomes in patients with schizophrenia, particularly those with cognitive impairment. Through participation in the CONNEX study program evaluating Iclepertin, the facility contributes valuable safety data for patients who have completed initial treatment phases, supporting the development of innovative therapies for this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Neurocrine Biosciences Inc.2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Neurocrine Biosciences Inc.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in GABINET LEKARSKI PSYCHIATRYCZNY IRENEUSZ KACZOROWSKI
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of 9-(4-Cyclohexyloxyphenyl)-7-Methyl-3,4-Dihydropyrazino[2,1-c][1,2,4]Thiadiazine 2,2-Dioxide as Adjunctive Therapy in Major Depressive Disorder | Neurocrine Biosciences Inc. | Phase III | Recruiting | Sep 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE | 2 | Unknown | 2025-09-19 | 2025-10-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.